Loader
Latest News
HRES1512: Providing for the concurrence by the House in the Senate amendment to H.R. 7776… (117th Congress)
20866
wp-singular,page-template-default,page,page-id-20866,wp-theme-bridge,bridge-core-3.3.4.9,qode-optimizer-1.2.3,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode_grid_1400,side_menu_slide_from_right,qode-theme-ver-30.8.9.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-9.0.1,vc_responsive
 

HRES1512: Providing for the concurrence by the House in the Senate amendment to H.R. 7776, with an…

117th Congress (2021–2023) · House resolution · Sponsor: Rep. Smith, Adam [D-WA-9]

This page covers HRES1512 in the 117th Congress. Bill numbers start over every Congress, so HRES1512 in another Congress is a different bill.

Providing for the concurrence by the House in the Senate amendment to H. R. 7776, with an amendment.


Key facts

Item Detail
Roll-call votes 1
Chamber House
Latest vote 2022-12-08: Passed
Latest action 2022-12-08: Motion to reconsider laid on the table Agreed to without objection.
Official record Congress.gov

What the bill does

This resolution provides for House adoption and amendment of H. R. 7776, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023.


Roll-call votes on HRES1512 (117th Congress)

Every recorded vote on this bill, newest first, with a link to the official tally. Member-by-member positions are on each member’s profile.

Date Chamber Question Result Yea Nay Not voting Record
2022-12-08 House 2/3 Yea-And-Nay Passed 246 54 0 Official tally

Frequently asked

What is HRES1512 in the 117th Congress?

HRES1512 (Providing for the concurrence by the House in the Senate amendment to H.R. 7776, with an amendment.) was introduced in the 117th Congress (2021–2023) by Rep. Smith, Adam [D-WA-9].

What is the latest action on HRES1512?

On 2022-12-08: Motion to reconsider laid on the table Agreed to without objection.

How many roll-call votes were held on HRES1512?

1 recorded vote in the 117th Congress. The most recent, on 2022-12-08, was "2/3 Yea-And-Nay": Passed.